InvestorsHub Logo
Followers 1
Posts 218
Boards Moderated 0
Alias Born 06/10/2020

Re: None

Thursday, 10/08/2020 10:18:26 PM

Thursday, October 08, 2020 10:18:26 PM

Post# of 144814
No one knows why the ind was put on hold. Anyone that says they do is just speculating. Speculations are not facts. We will find out soon enough what caused it to be put on hold. PMCB will attempt to fix the deficiencies. In the event pmcb is unable to fix the problem for whatever reason I suggest to move the study back to Europe or even China. There is no reason to fold and allow this technology to be shelved when this study has been duly accepted and sanctioned in Europe . Pancreatic cancer is global. PMCB doesnt have to market ciab in USA. Pmcb should do like Gilead did by having their drug approved in Europe and Japan even as it was rejected in USA. Its about survival literally for the company and for the people that may benefit from this technology. The fact is regulatory authorities from USA, EUROPE and Japan dont always see eye to eye even with harmonization in place. There are some drugs that have been rejected in Europe yet approved in USA and vice versa. So this is nothing new. CIAB is a real technology regardless of the negative comments on here. It is a technology that has been used on both human and animal and safely too. Yeah we are all disappointed but that is life nobody says it has to be fair.

We dont know if the problem is manufacturing related, Stability issues, data integrity, etc we just have to wait and see. Whatever be the case there is always Europe, Japan or China as an option.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News